To sum up, a greater PKC activity and a PI3K/AKT pathway hyperactivation could be responsible for the higher nNOS phosphorylation, the greater NO release and, consequently, the enhanced nitrergic function observed in HT. The gene discussed is PRRT2; the disease is hematocrit.